Innovative Health Care Models Prove Cost-Effective Amidst Pandemic Pressures

By Danélia Botes

September 26, 2023

During the COVID-19 pandemic, hospitals faced immense pressure. Singapore was also grappling with a dengue outbreak, adding to the strain on hospital capacity. This situation led to the rapid implementation of novel care models to treat patients with acute, low-severity medical conditions.

Two of these models, the hospital-at-home (HaH) and ambulatory care team (ACT) models, were used to treat patients with dengue and chest pain respectively. The HaH model allowed patients to receive care at home, while the ACT model provided timely care in a clinic-style setting at the hospital’s emergency department.

An economic evaluation aimed to compare the personnel cost of these models with conventional hospital inpatient care. The results showed that the HaH and ACT models used less personnel time, resulting in reduced costs.

The HaH model for treating dengue was found to be slightly cheaper than conventional care, with estimated savings of 18 SGD per case. The ACT model for treating chest pain showed more significant savings, with an estimated reduction of 126 SGD per case.

These innovative health care models not only alleviate hospital pressure but also potentially reduce hospital-acquired infections, length of stay, and overall health care expenditure. However, a reliable cost analysis of these models remains a priority.

Reference url

Recent Posts

Cost-effectiveness analysis Europe Neurological disorders Quality of Life 

Fremanezumab: Cost-Effective Relief for Chronic Migraine

Thanusha Pillay

Migraine is complex and debilitating neurological condition that contributes significantly to global disability. This condition is mostly prevalent in women during their childbearing and working years, and impacts the quality of life for both the patient and their families.

Fremanezumab is a new preventative migraine treatment that has the potential to provide relief to people with chronic migraine and to reduce the economic burden of this condition.

🌟 Discover the economic impact of fremanezumab in migraine management! 🌟 Our latest insight article highlights the first ever cost-effectiveness study for fremanezumab and its long-term benefits. #SyenzaNews #MigraineManagement #HealthcareEconomics #ValueBasedHealthcare

mental health sis
Artificial intelligence and machine learning Asia Data Analysis Evidence-based medicine Health economic evaluations Health Policy Healthcare access Mental health Policymakers 

Mental Health Disparities in South and East Asia: Research Priorities and Collaborative Strategies

Charmi Patel

🌟 Addressing Mental Health Disparities in South and East Asia 🧠🌏
Join the conversation on tackling unmet mental health needs and fostering research collaborations for a brighter, healthier future! #SyenzaNews#MentalHealth #ResearchPriorities #Collaboration #SouthEastAsiaMentalHealth 🤝

Anaprazole vs. Ilaprazole: A comparative analysis
Asia Comparative effectiveness research Cost-utility analysis Drug safety Health economic evaluations Healthcare systems Quality of Life 

Pharmacoeconomic Comparison of Anaprazole and Ilaprazole for Duodenal Ulcer Treatment in China

Melike Belenli Gümüş

🔍 Exploring anaprazole vs. ilaprazole for treating duodenal ulcers in China! 🏥 Discover the economic and clinical insights from a recent study comparing these novel PPIs. 📊💊 #SyenzaNews #Anaprazole #PPI #DuodenalUlcer #MedicalResearch

Learn more about the economic impact and clinical efficacy of Anaprazole in treating duodenal ulcers. Stay informed for better #HealthcareDecisions! 📚💡

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.
PARTNER WITH US
schedule a meeting

SPEAK WITH US

+1 617 219 9400

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

WRITE US

inquiry2023@syenza.com

JOIN NEWSLETTER




SERVICES

QUICK LINKS

LINKEDIN
TWITTER
© 2024 Syenza™. All rights reserved.
Made with by Frogiez
schedule a meeting